Leidos Holdings, Inc. (NYSE:LDOS - Get Free Report) Director Surya N. Mohapatra sold 2,748 shares of Leidos stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $194.97, for a total value of $535,777.56. Following the completion of the sale, the director now owns 20,001 shares of the company's stock, valued at $3,899,594.97. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
Leidos Stock Down 0.0 %
NYSE LDOS traded down $0.10 on Tuesday, reaching $201.29. 743,273 shares of the stock traded hands, compared to its average volume of 862,674. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.15 and a current ratio of 1.23. The company has a fifty day moving average price of $167.47 and a 200-day moving average price of $154.38. The company has a market cap of $26.86 billion, a price-to-earnings ratio of 22.94, a PEG ratio of 1.57 and a beta of 0.68. Leidos Holdings, Inc. has a 12 month low of $102.72 and a 12 month high of $202.90.
Leidos (NYSE:LDOS - Get Free Report) last issued its earnings results on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.96 by $0.97. The company had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.06 billion. Leidos had a return on equity of 30.31% and a net margin of 7.37%. The firm's quarterly revenue was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.03 EPS. As a group, research analysts forecast that Leidos Holdings, Inc. will post 10.09 EPS for the current fiscal year.
Leidos Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 16th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.79%. The ex-dividend date is Friday, December 13th. This is a positive change from Leidos's previous quarterly dividend of $0.38. Leidos's payout ratio is 18.22%.
Hedge Funds Weigh In On Leidos
A number of institutional investors have recently bought and sold shares of LDOS. Ballentine Partners LLC grew its position in Leidos by 3.5% during the 3rd quarter. Ballentine Partners LLC now owns 1,822 shares of the aerospace company's stock worth $297,000 after purchasing an additional 62 shares during the last quarter. Key Financial Inc boosted its stake in shares of Leidos by 6.5% in the 2nd quarter. Key Financial Inc now owns 1,141 shares of the aerospace company's stock valued at $166,000 after purchasing an additional 70 shares in the last quarter. Asahi Life Asset Management CO. LTD. increased its stake in shares of Leidos by 3.2% in the 3rd quarter. Asahi Life Asset Management CO. LTD. now owns 2,280 shares of the aerospace company's stock valued at $372,000 after acquiring an additional 70 shares during the last quarter. Bleakley Financial Group LLC grew its stake in Leidos by 2.9% in the 1st quarter. Bleakley Financial Group LLC now owns 2,671 shares of the aerospace company's stock valued at $350,000 after buying an additional 76 shares during the last quarter. Finally, Somerset Trust Co grew its holdings in shares of Leidos by 3.5% during the 3rd quarter. Somerset Trust Co now owns 2,429 shares of the aerospace company's stock valued at $396,000 after purchasing an additional 83 shares during the last quarter. 76.12% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
LDOS has been the topic of several research reports. Robert W. Baird upped their price target on Leidos from $180.00 to $218.00 and gave the company an "outperform" rating in a report on Wednesday, October 30th. Barclays increased their price objective on shares of Leidos from $165.00 to $210.00 and gave the company an "overweight" rating in a research note on Monday, November 4th. JPMorgan Chase & Co. boosted their price target on Leidos from $175.00 to $185.00 and gave the company an "overweight" rating in a report on Wednesday, October 2nd. TD Cowen increased their price target on Leidos from $175.00 to $200.00 and gave the stock a "buy" rating in a research note on Wednesday, October 30th. Finally, Bank of America increased their price objective on shares of Leidos from $160.00 to $165.00 and gave the company a "buy" rating in a research note on Wednesday, August 7th. Two analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Leidos currently has an average rating of "Moderate Buy" and an average price target of $191.23.
View Our Latest Report on Leidos
Leidos Company Profile
(
Get Free Report)
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Stories
Before you consider Leidos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leidos wasn't on the list.
While Leidos currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.